About Prevtec Microbia

Prevtec Microbia is a Canadian biotechnology company specialized in the development of vaccines and other technologies that help fight against bacterial diseases in food animals. In a world where antibiotic use in animal production is increasingly controlled, we develop innovative alternatives to antibiotics. Our products represent sustainable solutions. Prevtec Microbia is an innovation-centric company that operates in many areas of the world through strategic alliances, particularly in Canada and Europe. Prevtec Microbia is proud to be part of the quest for better ways to feed the world.
$33 billion

Estimated value of the global animal health industry by 2020*

* Vetnosis


Number of countries where Coliprotec® F4 is approved for use


We have been devising innovative solutions to challenges in livestock production for over a decade.

Investors urge fast food and pub chains to act to reduce farm antibiotics

https://www.theguardian.com/society/2016/apr/10/investors-fast-food-pub-chains-reduce-farm-antibiotics (c) Guardian News & Media Ltd

Prevtec Microbia will present at the European Animal Health Forum

Prevtec Microbia was selected as one of twelve emerging animal health companies to present at the first European Animal Health Investment Forum, taking place February 10-11, 2016 at the Royal Garden Hotel in London, UK.


    Antimicrobial resistance (AMR) is resistance of a microorganism to an antimicrobial medicine to which it was originally sensitive. AMR occurs naturally but the phenomenon is hugely increased by excessive and inappropriate use of antimicrobial medicines and poor infection control practices in animals and humans.



    Source: European Commission, http://europa.eu/rapid/press-release_STATEMENT-15-6097_en.htm